Chronic obstructive pulmonary disease (COPD) is a common respiratory disease characterized by a range of clinical features and variable course and response to therapy. 1, 2 To better understand the heterogeneous nature and trajectory of COPD, a number of large cohort studies have identified subgroups of patients that share common features, termed COPD phenotypes. [1] [2] [3] Among others, an asthma-COPD overlap, labeled as asthma-COPD overlap syndrome, is a proposed clinical COPD phenotype. Two subtypes of asthma-COPD overlap syndrome that may have different longterm prognosis have been proposed: an asthma-COPD overlap stemming from asthma and an asthma-COPD overlap stemming from COPD. 4, 5 A COPD phenotype resulting from chronic asthma is supported by longitudinal studies demonstrating that asthma can progress to chronic (fixed or incompletely reversible) airflow limitation in adults, independent of smoking history or other confounders. [5] [6] [7] [8] Little is known about the natural history of this type of COPD as compared with other COPD phenotypes. Evidence from longitudinal studies on long-term health outcomes associated with a history of asthma in individuals with COPD is limited and conflicting. 9 Although some studies found a significant association between concurrent or previously diagnosed asthma and an increased risk of all-cause mortality in individuals with COPD, [10] [11] [12] other studies did not. [13] [14] [15] Evidence on higher Abbreviations used COPD: Chronic obstructive pulmonary disease CV: Cardiovascular respiratory hospitalizations is stronger, [12] [13] [14] [16] [17] [18] although limited by a single-center study design, 13, 14 use of unvalidated measures, 16, 17 or small sample size and significant attrition rate. 13 In studies using health administrative data, concurrent asthma and COPD were defined as being diagnosed with both diseases at some point over a long period of time, increasing the possibility of misclassification. 16, 17 Other studies have examined outcomes using objective measures of airway obstruction; however, although some of the individuals studied might have had a history of asthma, others might have had onset of their asthma after COPD onset, and therefore likely constitute a different COPD phenotype. 12 The role of history of asthma in the association between COPD and cardiovascular (CV) risk is also unclear. 19, 20 Finally, we are not aware of studies that evaluated long-term consequences of COPD developed from chronic asthma.
Therefore, to fill this knowledge gap and learn more about COPD that has developed in patients with asthma, we compared long-term health outcomes in individuals with physician-diagnosed COPD that was and was not preceded by physician-diagnosed asthma using provincial health administrative data. We hypothesized that individuals with COPD and a history of asthma were at a higher risk of long-term adverse outcomes than those without.
Some of the results of these studies have been previously reported in the form of an abstract. 21 
METHODS

Study design
We conducted a population-based cohort study using provincial health administrative data for the period 1991 to 2013 from Ontario, the largest province of Canada with a population of approximately 13 million since 2010 as reported by Statistics Canada (Fig 1) . This study was approved by the institutional review board at Sunnybrook Health Sciences Centre, Toronto, Canada.
Data sources
In Ontario, details of health services provided to all residents by physicians and hospitals are captured in health administrative databases housed at the Institute for Clinical Evaluative Sciences. Service details can be linked at the individual level to provide a complete health services profile for each resident. We used the following databases: Hospitalization, Emergency Department Visits and Ambulatory Care Visits Databases, Permanent Resident Database of Citizenship and Immigration Canada, Canadian Community Health Survey, and Registered Persons Database. 22 The Canadian Community Health Survey is a national survey routinely used to collect information related to health status, health care utilization, and health determinants for the Canadian population based on a large subsample of individuals selected using various selection probabilities based on age and household composition. Details are provided elsewhere. 23 For a subsample of individuals from our cohort who completed this survey, information about smoking status and alcohol consumption was determined.
All data are held at the Institute for Clinical Evaluative Sciences and were linked using unique encoded identifiers.
Study population
All individuals with physician-diagnosed COPD between the ages 40 and 55 years were identified using a previously validated case definition based on health administrative data. 24 This definition consists of being 35 years and older and having 1 or more COPD hospital discharges and/or 3 or more COPD ambulatory care visits within a period of 2 years. 24, 25 This case definition had a sensitivity of 65.5% and a specificity of 91.5% when compared with real-world clinical evaluation by a physician (which may or may not have included spirometry), and has been used in previous studies.
24,25
The index date was defined as the date of hospital discharge for COPD or the date of the third COPD ambulatory visit, and this date was required to fall within the time frame of April 1, 2009, and March 31, 2011. We only included individuals between the ages of 40 and 55 years to minimize age as an effect modifier and to ensure that the diagnosis of asthma in our cohort was established during young adulthood or early middle-age to reduce the risk of diagnostic misclassification (ie, elderly patients with COPD initially improperly labeled as having asthma).
We excluded individuals with a history of chronic respiratory disease other than asthma, as well as those who died on the index date, non-Ontario residents, and those who were uninsured.
Exposure
Our primary exposure was a history of asthma at least 2 years before the index date. The exposure history was ascertained back to 1991. Two years was chosen to ensure that the asthma preceded COPD and was not as a result of an initial misdiagnosis. Physician-diagnosed asthma was defined, as with COPD, using a validated case definition of 1 or more asthma hospital discharges and/or 2 or more asthma ambulatory care visits within 2 years (specificity of 81.4%, sensitivity of 80.6% compared with evaluation by a physician). 26 Because pulmonary function information was not available in administrative data, we dichotomized patients as having poorly controlled and/or severe asthma versus well-controlled and/or mild to moderate asthma by their health services use. The former were those who were hospitalized at least once in the last 5 years before COPD diagnosis date; all others were determined to have well-controlled and/or mild to moderate asthma.
Outcomes
Individuals with COPD were followed from their index date to when they died, left the province, became uninsured, or the end of follow-up period (March 31, 2013), whichever occurred first. Our primary outcome was a composite consisting of time from the index date to the first instance of COPD hospitalization or all-cause mortality. We included mortality in our primary outcome because the high number of deaths in this population (a competing event) 27 may preclude hospitalization or greatly alter the chances to observe it, resulting in a biased estimate of hospitalization risk as a stand-alone outcome. 28 All-cause, as opposed to COPD-specific, mortality was chosen because a significant proportion of patients with COPD die of CV-related and other causes to which COPD has significantly contributed and that are not captured by the latter alone. 29, 30 In addition, COPD as a cause of mortality tends to be undercoded in death certificates. 30 Our secondary outcomes were (1) separate components of the composite outcome, (2) hospitalizations due to respiratory diseases (COPD, asthma, pneumonia and influenza, and acute bronchitis or bronchitis not specified as acute or chronic), (3) hospitalizations due to CV disease (chronic heart failure, myocardial infarction, stroke), 31 and (4) hospitalization or emergency department visits due to any cause.
Potential confounders and risk factors
The following factors were derived from the health administrative data: demographic characteristics; comorbidities at baseline (as separate conditions-eg, CV diseases, hypertension, diabetes, gastroesophageal reflux disease, atopic conditions and mental health conditions, and as an aggregate comorbidity measure 32, 33 ); factors related to COPD and general health care (having flu vaccination in the last year and spirometry in the last 5 years); and rural (vs urban) residence and immigrant status. Given that the change in diagnosis from asthma to COPD could represent diagnostic confusion and be a marker of poor care, we controlled for previous exposure to specialist care (primary care visits in last year, pulmonologist care visits in last 5 years). Details on these variables are provided in this article's Online Repository at www.jacionline.org.
Analyses
Descriptive statistics were calculated for general characteristics of the study population. Event-free survival was estimated using the Kaplan-Meier method and compared between groups with the log-rank test.
We modeled the propensity score to predict a history of asthma for patients with COPD from all the covariates listed above. Details on the propensity score modeling are provided in this article's Online Repository at www.jacionline.org. The absolute standardized mean difference of the effect size and the Kolmogorov-Smirnov statistic were used to assess the balances between individuals with and without a history of asthma. 34 Inverse probability of exposure (history of asthma) weighting using the propensity score method was used to remove the effect of confounding. [35] [36] [37] The hazard of the occurrence of adverse outcomes was regressed on an indicator variable denoting having a history of asthma using a Cox-proportional hazards model in the weighted sample.
38,39
Sensitivity analyses
To ensure the robustness of the results, we performed several sensitivity analyses. To evaluate whether the period of 2 years between the diagnosis of COPD and asthma in the primary exposure was sufficient, we also examined a history of asthma at least 1, 3, 4, and 5 years before the index date. To determine whether there was a ''dose-response effect'' based on the severity of asthma, we contrasted the effect of poorly controlled and/or severe versus well-controlled and/or mild/moderate asthma on the composite outcome. To adjust for potentially confounding factors not available in the health administrative data, we used the approach recommended by Lin et al 40 to assess the sensitivity of results to unmeasured confounders. Also, the subsample of individuals with available data from the Canadian Community Health Survey was used to explore the distribution of variables not available in the health administrative data, including smoking status and alcohol consumption. Depending on the sample size, propensity score calibration based on the Canadian Community Health Survey data was planned. 41 Furthermore, we used traditional multivariable Cox-proportional hazards regression adjusted for all covariates available on the entire sample to minimize potential bias associated with performing analyses only on weighted sample. To address limitations associated with composite outcome usage, 42 we also investigated the effect of history of asthma on secondary outcomes J ALLERGY CLIN IMMUNOL VOLUME 139, NUMBER 3 using the Fine and Gray competing-risk regressions to account for the competing risk of death. 43 Finally, to adjust for possible misclassification bias from using a COPD case definition with lower sensitivity, the analyses were replicated on a cohort defined using a more sensitive case definition of COPD (sensitivity of 85.0% and specificity of 78.4%). 24 All statistical analyses were performed in the secure environment of the Institute for Clinical Evaluative Sciences following provincial privacy standards using R version 2.15.2 (www.r-project.org). The package ''twang'' (Toolkit for Weighting and Analysis of Nonequivalent Groups) was used for the estimation and evaluation of propensity scores and associated weights. 34 
RESULTS
Sample description
There were 9053 patients aged 40 to 55 years with COPD included in our study (Fig 2) , of whom 2717 (30%) had a history of asthma. Compared with those without, patients with COPD with a history of asthma were more likely to be women, had a higher level of comorbidity, and were more likely to receive specialist care (Table I) .
Over a median time of 2.9 years (interquartile range, 2.3-3.4), 712 (8%) individuals had a first COPD hospitalization, 964 (10.7%) a first respiratory-related and 342 (3.8%) a first CV-related hospitalization, and 556 (6%) died (Table II) . A history of asthma was significantly associated with a lower unadjusted primary outcome-free survival (log-rank test: P < .001).
Main analyses
The propensity score method achieved excellent balance in baseline characteristics between individuals with and without a history of asthma (Table I; After adjustment for confounding, having a history of asthma was associated with 23% increased risk of the composite outcome of death or hospitalization for COPD (Table III) .
Sensitivity analyses
A history of asthma remained significantly associated with an increased risk of COPD hospitalization or all-cause mortality using other analytical approaches (see Tables E1-E3 in this article's Online Repository at www.jacionline.org). A history of Group without a history of asthma is presented as unweighted (original) and weighted* on the PS. The values in boldface represent the exposed and unexposed groups after PS weighting to show achieved balance in baseline characteristics between individuals with and without a history of asthma. Missing values: Income status (n missing 5 45), Rural (vs urban) residence (n missing 5 1). IQR, Interquartile range; KS, Kolmogorov-Smirnov; PS, propensity score. *In weight allocation using the average treatment effect on the treated (ATT) approach (used in our main analysis), exposure group has weight 1 and only controlled group is weighted. In weight allocation using the average treatment effect (ATE) approach (used in sensitivity analysis), both groups are weighted (see more details in this article's Online Repository at www.jacionline.org). àATT (average treatment effect among treated) approach. §Respiratory diseases: COPD, asthma, pneumonia and influenza, and acute bronchitis or bronchitis not specified as acute or chronic.
asthma up to 5 years preceding the COPD diagnostic date remained significantly associated with an increased risk of the composite outcome (P 5.02). We also confirmed the robustness of our findings while assessing the sensitivity of the results to potential unmeasured confounding (Figs 2 and 3) . The risk of COPD hospitalization or death was higher in people with poorly controlled and/or severe asthma compared with well-controlled and/or mild to moderate asthma (Table IV) .
Investigating secondary outcomes using Cox regression and competing-risk analyses, we found that a history of asthma was associated with increased hospitalizations due to COPD (Fig 3) , asthma, and other respiratory diseases, but not all-cause mortality (Fig 4) or CV-related hospitalizations (Table III) . A positive association with all-cause hospitalization and emergency department visits was also seen (Table III) .
Among 228 (38 with a history of asthma, 190 without) patients with COPD who completed the Canadian Community Health Survey, 32 (84%) individuals with a history of asthma smoked 100 or more cigarettes in life compared with 169 (89%) without a history of asthma (P 5.58). The difference in alcohol consumption was also not significant (P 5 .27). Propensity score calibration was not performed because of the small sample available.
DISCUSSION
We conducted a population-based study of a large cohort of middle-aged patients with physician-diagnosed COPD and found that the 30% of individuals who had a history of asthma had a 53% and 63% higher hazard of hospitalizations due to COPD and other respiratory diseases, respectively, then those without a history of asthma. Furthermore, individuals with more severe/less-controlled asthma did worse than those with milder/better-controlled asthma. However, the history of asthma was not associated with a higher hazard of CV hospitalizations or all-cause death. Our findings were found to be robust in multiple sensitivity analyses. To our knowledge, this is the first longitudinal large-scale population study that has investigated the long-term consequences associated with a history of asthma (as opposed to concurrent asthma, as in previous studies) in people with newly diagnosed COPD using validated definitions of COPD and asthma and a comprehensive analytic approach. Its results teach us about COPD that has developed from chronic asthma and can be used to alert clinicians to this high-risk group, and to create personalized COPD preventive and management strategies.
On population level, we confirmed the findings from other studies showing that people with concurrent asthma and COPD are at a higher risk of respiratory hospitalizations as compared with people with either COPD or asthma alone, which may be explained by worse lung function, more respiratory symptoms, and more frequent exacerbations in this population. 9, [12] [13] [14] [16] [17] [18] 44 Further studies are needed to elucidate the pathophysiologic processes that lead to the development or worsening of COPD in patients with asthma. 45 Our findings of no association with all-cause mortality are consistent with those of other studies. [13] [14] [15] However, we were possibly underpowered to show a difference in mortality as a stand-alone outcome (n total all-cause death 5 556). It is also possible that an asthma-COPD overlap stemming from COPD has a worse prognosis in terms of survival compared with COPD developed from asthma. 12 We were also likely underpowered to show a difference between a history of asthma and CV events (n total 5 342). Nonetheless, findings from the Copenhagen General Population Study that found that risks of CV comorbidities and death in individuals with asthma were restricted to smokers only 8 are one of the possible explanations. Thus, the fact that our groups did not appear to differ in proportion of smokers might have also contributed to why we did not find an association between a history of asthma and CV events or all-cause mortality.
The strengths of our study include its real-world and population relevance and power to examine the effects of a history of asthma on the development of adverse long-term consequences among patients with COPD.
Our study had some limitations (see all details in this article's Online Repository at www.jacionline.org). Unlike randomized controlled trials, observational designs are prone to unmeasured confounding. We addressed this by adjusting for many confounders in our statistical models and considered others, not available in the health administrative data, using different statistical techniques. We had to be careful, however, not to overcontrol for variables-such as lung function or medication use-that were on the causal pathway (ie, history of asthma leads to more severe COPD/more medication use and also COPD hospitalizations) 46 because adjusting for them would diminish a true association.
We also had limited information on smoking status. Because of the lack of data on smoking status for the majority of our cohort, it is uncertain whether asthma, cigarette smoking, or a combination of both factors is associated with COPD development and progression, and consequently long-term outcomes. 47 Furthermore, differences in smoking status between individuals with COPD with and without a history of asthma may influence the proportions with comorbid diseases at baseline as well as the outcomes occurrence. 8 However, we used a propensity score approach to control for possible imbalance in comorbidities at baseline between patients with and without a history of asthma. In addition, if we assume that in patients with a history of asthma, current smoking but not airway remodeling due to asthma predispose to adverse long-term COPD, the situation where current smoking is less prevalent in patients with a history of asthma than in those without would bias our results toward the null. A higher prevalence of smoking would need to be observed in individuals with a history of asthma to bias our results toward finding an effect of history of asthma in patients with COPD where none exists. According to our sensitivity analyses looking for a potential unmeasured confounder (details are available in this article's Online Repository at www.jacionline.org), the odds of prevalent smoking would need to be more than 2 times greater in individuals with a history of asthma than in those without a history of asthma, controlling for confounders and risk factors included in our statistical model, to render our findings null. We believe this situation implausible because, while some studies have shown a ''healthy smoker effect'' in people with asthma 48 and others have found no effect, 49 to our knowledge, there have been no studies that have shown higher smoking rates in people with asthma-COPD overlap compared with COPD only. 12, 50 In our study, a slightly lower prevalence of smoking was found in individuals with compared to without a history of asthma, albeit a relatively small subgroup. Because the difference was not statistically significant and limited by small sample size, it would have had little impact on our results or slightly biased them toward a smaller association between a history of asthma and outcomes.
With respect to identifying people with COPD, some patients with milder COPD may have been missed by the specific COPD case definition, causing the severity of COPD we studied to be higher than that of the average patient with COPD. However, repeating the analysis using a cohort of individuals with COPD identified using a more sensitive (albeit less specific) case definition yielded similar results. Using health administrative data to identify people with COPD and asthma might have also led to misclassification of one for the other. However, we studied young individuals who were more likely to be diagnosed with asthma than with COPD, and found consistent results when we increased the time between their diagnoses of asthma and COPD, decreasing the chance both labels were given because of diagnostic uncertainty. Also, the proportion of patients with COPD with a history of asthma and their characteristics are consistent with those in other studies. 9, 25, 50, 51 Individuals with compared to without a history of asthma were probably more likely to have seen a pulmonologist and receive an accurate COPD diagnosis; however, this limitation would have been alleviated by adjusting for past specialist care, as we did. Finally, although residual misclassification of diagnoses or outcomes may exist, we believe it to be minimal and reflective of the real-world environment and imperfect conditions and diagnoses that most patients and clinicians find themselves having to make clinical decisions.
Conclusions
In a large population of patients with physician-diagnosed COPD, a history of asthma was significantly associated with increased hazards of hospitalizations due to COPD and other respiratory diseases, but not due to CV diseases or all-cause mortality. Identifying the characteristics and prognosis of different COPD phenotypes allows the identification of high-risk groups that benefit from targeted preventive or management strategies that improve health outcomes.
Clinical implications: Subjects with COPD preceded by asthma are at a higher risk for hospitalizations due to COPD and other respiratory diseases. Identifying patients with asthma at risk for developing COPD would allow risk-stratification and development of targeted strategies.
